comparemela.com

Page 19 - Nasdaq Medp News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Joseph Group Capital Management Decreases Stake in Medpace Holdings, Inc (NASDAQ:MEDP)

Joseph Group Capital Management reduced its position in Medpace Holdings, Inc. (NASDAQ:MEDP – Get Rating) by 7.5% during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 2,932 shares of the company’s stock after selling 238 shares during the period. Joseph Group Capital […]

Medpace Holdings, Inc (NASDAQ:MEDP) Short Interest Up 18 2% in April

Medpace Holdings, Inc. (NASDAQ:MEDP – Get Rating) saw a large increase in short interest during the month of April. As of April 30th, there was short interest totalling 1,950,000 shares, an increase of 18.2% from the April 15th total of 1,650,000 shares. Currently, 8.4% of the company’s stock are short sold. Based on an average […]

Medpace (NASDAQ:MEDP) Stock Rating Upgraded by Guggenheim

Guggenheim upgraded shares of Medpace (NASDAQ:MEDP – Get Rating) from a neutral rating to a buy rating in a report released on Monday morning, The Fly reports. The brokerage currently has $252.00 price objective on the stock. MEDP has been the subject of several other research reports. Robert W. Baird lifted their price target on […]

Schulhoff & Co Inc Has $426,000 Stock Position in Medpace Holdings, Inc (NASDAQ:MEDP)

Schulhoff & Co. Inc. trimmed its position in Medpace Holdings, Inc. (NASDAQ:MEDP – Get Rating) by 33.3% in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 2,005 shares of the company’s stock after selling 1,000 shares during the quarter. Schulhoff & Co. Inc.’s […]

Medpace (NASDAQ:MEDP) Lifted to Buy at Guggenheim

Guggenheim upgraded shares of Medpace (NASDAQ:MEDP – Get Rating) from a neutral rating to a buy rating in a research note released on Monday, The Fly reports. They currently have $252.00 price target on the stock. MEDP has been the subject of a number of other research reports. StockNews.com lowered shares of Medpace from a […]

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.